Literature DB >> 22345477

Biological characterization and next-generation genome sequencing of the unclassified Cotia virus SPAn232 (Poxviridae).

Priscila P Afonso1, Patrícia M Silva, Laila C Schnellrath, Desyreé M Jesus, Jianhong Hu, Yajie Yang, Rolf Renne, Marcia Attias, Richard C Condit, Nissin Moussatché, Clarissa R Damaso.   

Abstract

Cotia virus (COTV) SPAn232 was isolated in 1961 from sentinel mice at Cotia field station, São Paulo, Brazil. Attempts to classify COTV within a recognized genus of the Poxviridae have generated contradictory findings. Studies by different researchers suggested some similarity to myxoma virus and swinepox virus, whereas another investigation characterized COTV SPAn232 as a vaccinia virus strain. Because of the lack of consensus, we have conducted an independent biological and molecular characterization of COTV. Virus growth curves reached maximum yields at approximately 24 to 48 h and were accompanied by virus DNA replication and a characteristic early/late pattern of viral protein synthesis. Interestingly, COTV did not induce detectable cytopathic effects in BSC-40 cells until 4 days postinfection and generated viral plaques only after 8 days. We determined the complete genomic sequence of COTV by using a combination of the next-generation DNA sequencing technologies 454 and Illumina. A unique contiguous sequence of 185,139 bp containing 185 genes, including the 90 genes conserved in all chordopoxviruses, was obtained. COTV has an interesting panel of open reading frames (ORFs) related to the evasion of host defense, including two novel genes encoding C-C chemokine-like proteins, each present in duplicate copies. Phylogenetic analysis revealed the highest amino acid identity scores with Cervidpoxvirus, Capripoxvirus, Suipoxvirus, Leporipoxvirus, and Yatapoxvirus. However, COTV grouped as an independent branch within this clade, which clearly excluded its classification as an Orthopoxvirus. Therefore, our data suggest that COTV could represent a new poxvirus genus.

Entities:  

Mesh:

Year:  2012        PMID: 22345477      PMCID: PMC3347363          DOI: 10.1128/JVI.07162-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  The genome sequence of Yaba-like disease virus, a yatapoxvirus.

Authors:  H J Lee; K Essani; G L Smith
Journal:  Virology       Date:  2001-03-15       Impact factor: 3.616

2.  Genome of lumpy skin disease virus.

Authors:  E R Tulman; C L Afonso; Z Lu; L Zsak; G F Kutish; D L Rock
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Velvet: algorithms for de novo short read assembly using de Bruijn graphs.

Authors:  Daniel R Zerbino; Ewan Birney
Journal:  Genome Res       Date:  2008-03-18       Impact factor: 9.043

Review 4.  When good vaccines go wild: Feral Orthopoxvirus in developing countries and beyond.

Authors:  Nissin Moussatché; Clarissa R Damaso; Grant McFadden
Journal:  J Infect Dev Ctries       Date:  2008-06-01       Impact factor: 0.968

5.  Yaba-like disease virus: an alternative replicating poxvirus vector for cancer gene therapy.

Authors:  Y Hu; J Lee; J A McCart; H Xu; B Moss; H R Alexander; D L Bartlett
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  Cell surface expression of the vaccinia virus complement control protein is mediated by interaction with the viral A56 protein and protects infected cells from complement attack.

Authors:  Natasha M Girgis; Brian C Dehaven; Xin Fan; Kendra M Viner; Mohammad Shamim; Stuart N Isaacs
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

7.  Araçatuba virus: a vaccinialike virus associated with infection in humans and cattle.

Authors:  Giliane de Souza Trindade; Flávio Guimarães da Fonseca; João Trindade Marques; Maurício Lacerda Nogueira; Luiz Claudio Nogueira Mendes; Alexandre Secorun Borges; Juliana Regina Peiró; Edviges Maristela Pituco; Cláudio Antônio Bonjardim; Paulo César Peregrino Ferreira; Erna Geessien Kroon
Journal:  Emerg Infect Dis       Date:  2003-02       Impact factor: 6.883

Review 8.  Vaccinia virus morphogenesis and dissemination.

Authors:  Kim L Roberts; Geoffrey L Smith
Journal:  Trends Microbiol       Date:  2008-09-12       Impact factor: 17.079

9.  Brazilian Vaccinia virus strains are genetically divergent and differ from the Lister vaccine strain.

Authors:  Betânia Paiva Drumond; Juliana Almeida Leite; Flávio Guimarães da Fonseca; Cláudio Antônio Bonjardim; Paulo César Peregrino Ferreira; Erna Geessien Kroon
Journal:  Microbes Infect       Date:  2007-11-28       Impact factor: 2.700

10.  Spread of cantagalo virus to northern Brazil.

Authors:  Maria Luiza G Medaglia; Leila Cristina G D Pessoa; Elisabeth R C Sales; Tânia R P Freitas; Clarissa R Damaso
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

View more
  19 in total

1.  Genomic Analysis, Phenotype, and Virulence of the Historical Brazilian Smallpox Vaccine Strain IOC: Implications for the Origins and Evolutionary Relationships of Vaccinia Virus.

Authors:  Maria Luiza G Medaglia; Nissin Moussatché; Andreas Nitsche; Pjotr Wojtek Dabrowski; Yu Li; Inger K Damon; Carolina G O Lucas; Luciana B Arruda; Clarissa R Damaso
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

2.  Diagnosis and successful treatment of Brazillian porcupine poxvirus infection in a free-ranging hairy dwarf porcupine (Coendu spinosus).

Authors:  Juliana Mariotti Guerra; Pedro Enrique Navas-Suárez; Eduardo Ferreira-Machado; Ticiana Brasil Ervedosa; Ketlyn Bolsachini Figueiredo; Ana Carolina Souza Ramos de Carvalho; Maraya Lincoln Silva; Mayara Grego Caiaffa; André Luiz Mota da Costa; Rodrigo Hidalgo Friciello Teixeira; Thais Eleonora Madeira Buti; Adriana Luchs; Gislene Mitsue Namiyama; Luana Barbosa de Lima; Noemi Nosomi Taniwaki; Patricia Sayuri Silvestre Matsumoto; Natália Coelho Couto de Azevedo Fernandes
Journal:  Braz J Microbiol       Date:  2022-07-29       Impact factor: 2.214

Review 3.  The poxvirus C7L host range factor superfamily.

Authors:  Jia Liu; Stefan Rothenburg; Grant McFadden
Journal:  Curr Opin Virol       Date:  2012-10-25       Impact factor: 7.090

Review 4.  Poxviruses and the evolution of host range and virulence.

Authors:  Sherry L Haller; Chen Peng; Grant McFadden; Stefan Rothenburg
Journal:  Infect Genet Evol       Date:  2013-10-24       Impact factor: 3.342

5.  Complete Genome Sequence of the Embu Virus Strain SPAn880.

Authors:  M Sofi Ibrahim; Markus Antwerpen; Enrico Georgi; Philipp Vette; Gudrun Zoeller; Hermann Meyer
Journal:  Genome Announc       Date:  2014-12-04

Review 6.  Poxviral ankyrin proteins.

Authors:  Michael H Herbert; Christopher J Squire; Andrew A Mercer
Journal:  Viruses       Date:  2015-02-16       Impact factor: 5.048

7.  Serological study of vaccinia virus reservoirs in areas with and without official reports of outbreaks in cattle and humans in São Paulo, Brazil.

Authors:  Marina Gea Peres; Thais Silva Bacchiega; Camila Michele Appolinário; Acácia Ferreira Vicente; Susan Dora Allendorf; João Marcelo Azevedo Paula Antunes; Sabrina Almeida Moreira; Emerson Legatti; Clóvis Rinaldo Fonseca; Edviges Maristela Pituco; Liria Hiromi Okuda; José Carlos de Figueiredo Pantoja; Fernando Ferreira; Jane Megid
Journal:  Arch Virol       Date:  2013-06-13       Impact factor: 2.574

8.  Population genomics supports baculoviruses as vectors of horizontal transfer of insect transposons.

Authors:  Clément Gilbert; Aurélien Chateigner; Lise Ernenwein; Valérie Barbe; Annie Bézier; Elisabeth A Herniou; Richard Cordaux
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

Review 9.  Poxviruses in bats … so what?

Authors:  Kate S Baker; Pablo R Murcia
Journal:  Viruses       Date:  2014-04-03       Impact factor: 5.048

10.  The genome sequence of ectromelia virus Naval and Cornell isolates from outbreaks in North America.

Authors:  Carla Mavian; Alberto López-Bueno; Neil A Bryant; Kathy Seeger; Michael A Quail; David Harris; Bart Barrell; Antonio Alcami
Journal:  Virology       Date:  2014-07-05       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.